Foresite Capital Management Iv, LLC Solid Biosciences Inc. Transaction History

Foresite Capital Management Iv, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 14, 2018	SELL	$7.33 - $43.15 $1.03 Million - $6.06 Million	-140,332 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$7.19 - $33.17 $1.01 Million - $4.65 Million	140,332 New	140,332 $1.05 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $43.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.